Biomedicine
Expertise by research divisions
Biomedical know how by research divisions
|
Biomedical | ||||||||
| Solar energy |
|||||||||
| Crystalline silicon solar cells | |||||||||
| Thin-film solar cells (perovskite, CIGS, silicon) | |||||||||
| Tandem solar cells (perovskite CIGS, perovskite silicon, silicon silicon) | |||||||||
| Solar module technology | |||||||||
| Building-integrated photovoltaics (BIPV) | |||||||||
| Chemical energy conversion and storage |
|||||||||
| Solar hydrogen production | RD | D | ILA | ||||||
| Conversion of carbon dioxide | |||||||||
| Battery systems (lithium, metal-sulphur) | RD | D | ILA | ||||||
| Electrodes (metal oxides, silicon) | |||||||||
| Catalysts (metal oxides) | |||||||||
| Quantum and Functional Materials |
|||||||||
| Control of spin-based phenomena (spintronics) | RD | D | ILA | ||||||
| Control of collective states (quantum magnets, supercond., ferroelectrics) | RD | D | ILA | ||||||
| Topological insulators | RD | D | ILA | ||||||
| Nanomagnetic systems | RD | D | ILA | ||||||
| Multiferroic materials | RD | D | ILA | ||||||
| Application of photons for research and development |
|||||||||
| Understanding and controlling how materials work | RD | D | ILA | ||||||
| Chemical reactions at the atomic level | |||||||||
| Phase transitions and switching processes | RD | D | ILA | ||||||
| Optimising the conversion of light into energy | |||||||||
| Optimisation of biochemical processes | |||||||||
| Scientific services and key components |
|||||||||
| Synchrotron beamlines and sample environments | |||||||||
| Superconducting cavities and electron guns | |||||||||
| Precision diffraction gratings and x-ray optics | |||||||||
| Undulators | |||||||||
| Proton and gamma irradiation sources for radiation hardness tests | |||||||||
Biomedical research examples
- Eye tumor therapy
- Protein crystallography
- Structural elucidation of proteins
- Residual stress analysis
- Tomography
- time-resolved X-ray spectroscopy
Eye tumor therapy

Together with the Charité, HZB operates facilities for
eye tumor therapy at the proton accelerator ring at the Wannsee site.